ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $151,000 | -93.7% | 33,035 | -90.1% | 0.00% | -95.0% |
| Q2 2015 | $2,414,000 | -66.8% | 334,750 | -66.1% | 0.02% | -67.2% |
| Q1 2015 | $7,274,000 | +106.9% | 986,962 | +32.7% | 0.06% | +103.3% |
| Q4 2014 | $3,516,000 | +43.3% | 743,477 | +8.2% | 0.03% | +36.4% |
| Q3 2014 | $2,453,000 | -17.6% | 687,013 | +5.3% | 0.02% | -18.5% |
| Q2 2014 | $2,976,000 | +100.4% | 652,515 | +106.6% | 0.03% | +28.6% |
| Q1 2014 | $1,485,000 | +44.2% | 315,830 | +53.7% | 0.02% | +31.2% |
| Q4 2013 | $1,030,000 | +39.9% | 205,545 | +73.7% | 0.02% | +23.1% |
| Q3 2013 | $736,000 | +33.6% | 118,320 | -2.6% | 0.01% | +30.0% |
| Q2 2013 | $551,000 | – | 121,470 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |